☰
Companies
▾
Companies
Calendar
Valuation
Screener
▾
Screener
Sectors
Magic Formula
Bubble Plot
Treemap
Chart Builder
Analysis
▾
Margins
Dividends
Buybacks
Insider Buying
CEO Changes
M&A Tracker
IPO Tracker
Short Selling
Markets
▾
Countries
US vs EU P/E
Fear & Greed
AI Models
AI Capex
Credit & Rates
▾
EU Yield Curve
US Yield Curve
US Federal Debt
Leverage
Repo Market
Mortgage Delinquency
Private Credit
Health
▾
Top Drugs
Diabetes
Immunology
Portfolio
▾
Portfolio
Berkshire
Buffett
Fund X-Ray
More
▾
Denmark
Danish Tax
Tesla
EU XBRL Tables
Contact
Obesity
Blog
Regeneron Pharmaceuticals Inc
REGN
☆
Healthcare
·
USA
·
USD
·
Ex-Div 2026-08-18
·
regeneron.com
Fundamentals
Gross Margin
96.6%
Op. Margin
24.9%
Net Margin
31.4%
ROIC
10.2%
Rev Growth
1.0%
Valuation
Price
836.72 USD
Day
+0.99%
52-Week Range
541.00 - 847.00
Market Cap
86.1B USD
Fwd P/E
13.8x
EV/EBITDA
16.5x
Div Yield
0.45%
Financial Data
#
Annual
Quarterly
TTM
Income Statement
Margins
Cash Flow
Balance Sheet
Dividends
Shares
Position
Liquidity
Share Count
Buybacks
Segment Breakdown
#
Price & Multiples
#
Price
P/S
EV/S
EV/EBITDA
P/E
1Y
2Y
5Y
10Y
All
vs S&P 500
Peers
#
MRNA
VRTX
RVMD
RPRX
ALNY
INSM
ROIV
INCY
UTHR
JAZZ
·
Compare in Screener
Dividends
Bubble
Gross Margin
Op. Margin
Net Margin
Fwd P/E
ROIC
Capex Intensity
Rev. Growth
Growth vs Margin
Revenue Mix
#
By Business Area
By Product
By Geography
Annual
Quarterly
TTM
Events
#
All
Insider
Earnings
Dividends
Date
Type
Details
Price
Amount
See also:
Healthcare in Screener
Treemap - USA
USA in Screener